Reversal In CAR-T Patent Battle Shows Federal Circuit’s Preference For Narrow Claims

 
• By Brenda Sandburg
CAR T-cell immunotherapy
Gilead wins reversal in CAR T-cell immunotherapy patent battle • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies